Nonsteroidal Anti-Inflammatory Drug (NSAID) Toxicity

Nonsteroidal anti-inflammatory drug (NSAID) toxicity refers to the adverse clinical syndrome resulting from excessive ingestion, overdose, or inappropriate use of NSAIDs in dogs and cats. These drugs are widely used for their analgesic, anti-inflammatory, and antipyretic properties, but they carry a narrow therapeutic index in veterinary species, particularly in cats. Toxicity can manifest as gastrointestinal ulceration, acute kidney injury (AKI), hepatotoxicity, and central nervous system signs, depending on the specific agent, dose, and species. The syndrome encompasses both acute accidental ingestion and chronic overdosage, with clinical signs ranging from mild vomiting to life-threatening perforating ulcers, renal failure, and coagulopathy. The severity is influenced by the specific NSAID, its half-life, metabolism, and the presence of concurrent risk factors such as dehydration, hypotension, or pre-existing renal disease.

The primary causative agents are NSAIDs, which include both over-the-counter human medications (e.g., ibuprofen, naproxen, aspirin) and veterinary-approved drugs (e.g., carprofen, meloxicam, deracoxib, firocoxib, robenacoxib). Toxicity occurs when animals ingest doses exceeding the therapeutic range, often due to accidental access to human medications, owner error in dosing, or off-label use. The mechanism involves inhibition of cyclooxygenase (COX) enzymes, with varying selectivity for COX-1 and COX-2. COX-1 inhibition leads to decreased production of cytoprotective gastric prostaglandins, while COX-2 inhibition reduces inflammatory mediators but also affects renal hemodynamics. In cats, deficient glucuronidation pathways lead to prolonged half-lives and increased susceptibility. Specific agents: ibuprofen (half-life ~4-6 hours in dogs, but longer in cats), naproxen (half-life ~35-74 hours in dogs), carprofen (half-life ~8 hours in dogs, ~19 hours in cats), meloxicam (half-life ~24 hours in dogs, ~15 hours in cats). Toxicity can also result from concurrent use of multiple NSAIDs or combination with corticosteroids, which synergistically increase gastrointestinal injury.

NSAID toxicity is one of the most common toxicities reported in small animal practice, particularly in dogs. It accounts for a significant percentage of calls to animal poison control centers. Dogs are more frequently affected due to their indiscriminate eating habits and higher likelihood of accessing human medications. Cats are less commonly affected but suffer more severe consequences due to their unique metabolism. There is no breed or sex predilection, but young animals may be more prone to accidental ingestion, while older animals may be more susceptible to renal and gastrointestinal effects due to age-related decline in organ function. Geographic variation exists based on the availability of specific NSAIDs. The incidence peaks during holidays or periods when owners are more likely to have medications accessible. Chronic toxicity is more common in animals receiving long-term NSAID therapy for osteoarthritis, especially if dosing guidelines are not followed or if concurrent diseases are present.

The pathophysiology of NSAID toxicity is multifaceted. The primary mechanism is inhibition of cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins. Prostaglandins are critical for maintaining gastric mucosal integrity, renal blood flow, and platelet function. In the gastrointestinal tract, reduced prostaglandin E2 (PGE2) and prostacyclin (PGI2) lead to decreased mucus and bicarbonate secretion, reduced mucosal blood flow, and increased gastric acid secretion, resulting in mucosal injury, erosion, and ulceration. This can progress to perforation and peritonitis. In the kidneys, prostaglandins (especially PGE2 and PGI2) are vasodilatory and help maintain renal perfusion during hypotension or dehydration. Their inhibition leads to renal vasoconstriction, reduced glomerular filtration rate (GFR), and acute tubular necrosis, particularly in the medullary region. The renal effects are exacerbated by concurrent volume depletion, hypotension, or pre-existing renal disease. Additionally, some NSAIDs, such as ibuprofen and naproxen, can cause direct tubular toxicity. Hepatotoxicity may occur due to idiosyncratic reactions or direct mitochondrial injury, leading to hepatocellular necrosis. Central nervous system signs, such as depression, ataxia, and seizures, can result from severe metabolic disturbances, uremia, or direct drug effects, especially in cats. Coagulopathy may arise from platelet dysfunction due to COX-1 inhibition, leading to prolonged bleeding times.

Several factors increase the risk of NSAID toxicity. Intrinsic factors include species (cats are more susceptible due to deficient glucuronidation), age (very young and very old animals have reduced drug metabolism and renal function), and pre-existing conditions such as chronic kidney disease, hepatic insufficiency, gastrointestinal disease, or hypotension. Genetic polymorphisms in drug-metabolizing enzymes (e.g., CYP2C9 in humans) may also play a role, though less is known in dogs and cats. Extrinsic factors include accidental ingestion of human NSAIDs, which are often more toxic due to higher potency or longer half-lives. Concurrent use of other NSAIDs, corticosteroids, or anticoagulants increases the risk of gastrointestinal ulceration and bleeding. Inappropriate dosing, such as exceeding the recommended dose or frequency, is a common cause. Dehydration, hypovolemia, or concurrent diuretic use can precipitate renal toxicity. Stress, poor nutrition, and concurrent infections may also exacerbate the effects.

Clinical signs of NSAID toxicity vary depending on the dose, time since ingestion, and species. In the peracute phase (within 1-4 hours), signs may be absent or mild, but early gastrointestinal signs such as vomiting, diarrhea, and anorexia can occur. Acute signs (within 12-24 hours) include vomiting (often with blood), hematemesis, melena, abdominal pain, and depression. As toxicity progresses, signs of renal injury may appear within 24-72 hours, including polyuria, polydipsia, dehydration, and in severe cases, oliguria or anuria. Chronic toxicity may present with weight loss, chronic vomiting, and signs of renal failure. In cats, signs may be more subtle initially, with lethargy, anorexia, and vomiting, but can rapidly progress to acute renal failure. Central nervous system signs such as ataxia, seizures, and coma may occur in severe cases, especially with high doses of ibuprofen or naproxen. Physical examination may reveal pale mucous membranes, prolonged capillary refill time, abdominal pain on palpation, and signs of shock in severe cases. In cases of gastrointestinal perforation, acute abdomen, fever, and septic peritonitis may be evident.

Differential diagnoses for NSAID toxicity include other causes of acute gastrointestinal signs and renal failure. These include: (1) Other toxicities such as ethylene glycol (antifreeze) poisoning, which also causes vomiting and acute renal failure, but is characterized by calcium oxalate crystalluria and metabolic acidosis. (2) Infectious gastroenteritis (e.g., parvovirus in dogs, panleukopenia in cats) which presents with vomiting, diarrhea, and leukopenia, but lacks a history of drug exposure. (3) Pancreatitis, which causes vomiting, abdominal pain, and elevated pancreatic lipase immunoreactivity (PLI). (4) Acute renal failure from other causes such as leptospirosis, which presents with fever, jaundice, and renal tubular damage, diagnosed via serology or PCR. (5) Gastrointestinal foreign body or obstruction, which may cause vomiting and abdominal pain, but is diagnosed via imaging. (6) Hepatic failure from other toxins (e.g., aflatoxin) or infectious causes, which may present with vomiting, jaundice, and elevated liver enzymes. (7) Hypoadrenocorticism (Addison's disease), which can cause vomiting, diarrhea, and electrolyte abnormalities, but is differentiated by ACTH stimulation test. (8) Coagulopathies such as rodenticide toxicity, which cause bleeding but are differentiated by prolonged clotting times and vitamin K response. A thorough history of drug exposure is crucial in differentiating NSAID toxicity from these conditions.

The diagnostic approach to suspected NSAID toxicity begins with a thorough history, including the specific drug, dose, time of ingestion, and any concurrent medications. Physical examination should focus on hydration status, abdominal palpation, and signs of bleeding. Initial diagnostic tests include a complete blood count (CBC), serum biochemistry profile, and urinalysis. CBC may reveal anemia, thrombocytopenia, or leukocytosis. Biochemistry may show elevated renal parameters (BUN, creatinine), liver enzymes (ALT, AST), and electrolyte imbalances. Urinalysis may reveal low urine specific gravity, proteinuria, and casts. Blood gas analysis may show metabolic acidosis. If ingestion is recent (<2 hours), emesis may be induced, and activated charcoal may be administered. However, if clinical signs are present, decontamination is contraindicated. Baseline renal and hepatic function should be assessed, and if there is any suspicion of renal injury, urine output should be monitored. In cases of gastrointestinal ulceration, abdominal radiographs or ultrasound may be performed to rule out perforation. Endoscopy can confirm gastric ulcers. For specific NSAID levels, serum drug concentrations are not routinely available but may be measured in some laboratories. A definitive diagnosis is often based on history and clinical signs, with supportive laboratory findings. In chronic toxicity, monitoring of renal and hepatic parameters over time is essential.

Hematology: Anemia may be present due to gastrointestinal bleeding, with decreased hematocrit and hemoglobin. Microcytic hypochromic anemia may be seen in chronic blood loss. Leukocytosis may occur due to stress or inflammation. Thrombocytopenia may be present if there is significant bleeding or if the NSAID affects platelet function. Serum Biochemistry: Elevated BUN and creatinine indicate renal injury. Hyperphosphatemia may also be present. Liver enzymes (ALT, AST, ALP) may be elevated, especially with hepatotoxicity. Hypoalbuminemia may occur due to protein-losing enteropathy or hepatic dysfunction. Electrolyte imbalances include hyponatremia, hyperkalemia (especially in oliguric renal failure), and metabolic acidosis. Urinalysis: Urine specific gravity may be low (<1.030 in dogs, <1.035 in cats) in renal failure. Proteinuria may be present due to tubular damage. Sediment may show renal tubular epithelial cells, casts, and red blood cells. Blood Gas Analysis: Metabolic acidosis with decreased bicarbonate and base excess is common. Specific Biomarkers: Urinary biomarkers such as kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) may be elevated in early renal injury. Serum symmetric dimethylarginine (SDMA) is a more sensitive marker of decreased GFR than creatinine. Coagulation profile: Prolonged bleeding time may be seen due to platelet dysfunction, but PT/PTT are usually normal unless there is severe liver failure.

Radiography: Abdominal radiographs may show evidence of gastrointestinal ulceration, such as gas patterns, or free air in the abdomen if perforation has occurred. However, radiographs are not sensitive for detecting ulcers. Thoracic radiographs may be indicated if aspiration pneumonia is suspected. Ultrasonography: Abdominal ultrasound is useful for evaluating the kidneys (size, echogenicity, cortical thickness) and gastrointestinal tract (wall thickness, loss of layering). It can also detect free fluid in the abdomen, suggestive of perforation. Doppler ultrasound can assess renal blood flow. Computed Tomography (CT): CT may be used to evaluate the gastrointestinal tract for perforation or to assess renal perfusion, but is not routinely necessary. Magnetic Resonance Imaging (MRI): MRI is rarely used in NSAID toxicity, but may be indicated if central nervous system signs are present. Endoscopy: Upper gastrointestinal endoscopy is the gold standard for diagnosing gastric and duodenal ulcers. It allows direct visualization of mucosal lesions and biopsy. Fluoroscopy: Not typically used. Echocardiography: Not directly relevant, but may be performed if there is concern for cardiac effects due to electrolyte imbalances.

Fine Needle Aspirate (FNA): FNA of the kidneys or liver may be performed if there is suspicion of infiltrative disease, but is not typically diagnostic for NSAID toxicity. Fluid Analysis: If peritoneal fluid is present, abdominocentesis may be performed. The fluid may be a modified transudate or exudate, with high protein and nucleated cell counts if peritonitis is present. Histopathology: Renal biopsy may show acute tubular necrosis, with degeneration and sloughing of tubular epithelial cells, interstitial edema, and casts. Liver biopsy may show hepatocellular necrosis, fatty change, or cholestasis. Gastrointestinal biopsy may reveal mucosal erosion, ulceration, and inflammatory infiltrate. Special stains such as Masson's trichrome may be used to assess fibrosis in chronic cases.

Treatment of NSAID toxicity is primarily supportive and symptomatic. The first step is decontamination if ingestion occurred within 2 hours and the animal is asymptomatic. Emesis can be induced with apomorphine (0.03 mg/kg IV or 0.04 mg/kg IM in dogs) or hydrogen peroxide (not recommended in cats). Activated charcoal (1-2 g/kg PO) may be administered to reduce absorption. However, if clinical signs are present, decontamination is contraindicated. Aggressive fluid therapy is essential to maintain renal perfusion and prevent acute kidney injury. Isotonic crystalloids such as lactated Ringer's solution or Normosol-R should be administered at a rate to maintain urine output (2-5 ml/kg/hr). In cases of oliguric renal failure, diuretics such as furosemide (1-2 mg/kg IV) or mannitol (0.5-1 g/kg IV over 20 minutes) may be used, but only after adequate hydration. Gastrointestinal protectants are crucial: proton pump inhibitors such as omeprazole (0.7-1 mg/kg PO q12h) or H2 antagonists such as famotidine (0.5-1 mg/kg IV/PO q12h) reduce gastric acid secretion. Sucralfate (0.5-1 g PO q8h) can be administered to coat ulcers. Misoprostol (2-5 mcg/kg PO q8h) is a synthetic prostaglandin analog that may help restore mucosal protection, but its use is controversial due to potential side effects. For severe gastrointestinal bleeding, blood transfusions may be necessary. Anti-emetics such as maropitant (1 mg/kg SC q24h) or ondansetron (0.1-0.2 mg/kg IV q8h) can control vomiting. In cases of hepatotoxicity, N-acetylcysteine (140 mg/kg IV loading dose, then 70 mg/kg q6h) may be beneficial. For central nervous system signs, anticonvulsants such as diazepam (0.5-1 mg/kg IV) may be used. In severe cases, hemodialysis or peritoneal dialysis may be considered for renal failure. Surgical intervention is indicated if gastrointestinal perforation occurs.

The prognosis for NSAID toxicity depends on the dose, time to treatment, and presence of pre-existing conditions. With prompt and aggressive treatment, the prognosis is generally good for mild to moderate toxicity. However, if acute kidney injury develops, the prognosis is guarded, with mortality rates ranging from 20-50%. Negative prognostic indicators include oliguria or anuria, severe azotemia, hyperkalemia, and the need for dialysis. Gastrointestinal perforation carries a poor prognosis, with high mortality. Chronic toxicity may lead to irreversible renal damage, requiring long-term management. In cats, the prognosis is often worse due to their increased susceptibility. Early intervention within 12 hours of ingestion significantly improves outcomes. Response to treatment, such as normalization of renal parameters within 72 hours, is a positive sign. Recurrence is unlikely if the underlying cause is addressed, but animals with pre-existing renal disease may have a poorer long-term prognosis.

Follow-up care is essential for animals recovering from NSAID toxicity. Re-check appointments should be scheduled at 48-72 hours after initial treatment to monitor renal and hepatic parameters. Serial blood work, including BUN, creatinine, electrolytes, and liver enzymes, should be performed every 24-48 hours until stable. Urine output should be monitored closely, and urine specific gravity and proteinuria should be assessed. In cases of renal injury, long-term monitoring of blood pressure and proteinuria is recommended, as hypertension and proteinuria may develop. Repeat imaging, such as ultrasound, may be indicated to assess renal architecture. If gastrointestinal ulceration was present, a follow-up endoscopy may be performed after 2-4 weeks to confirm healing. Owners should be educated on the importance of keeping all medications out of reach and using only veterinary-approved NSAIDs at prescribed doses. For animals with chronic renal disease, a renal diet and regular monitoring of SDMA and creatinine are recommended. Dose adjustments of any future NSAIDs should be made cautiously, and alternative analgesics may be considered.

Pearls: Always obtain a thorough history of any medication exposure, including human drugs. In cats, even a single dose of ibuprofen can be fatal; never administer human NSAIDs to cats. Early decontamination within 2 hours can significantly reduce toxicity. Aggressive fluid therapy is the cornerstone of treatment to prevent renal injury. Gastroprotectants should be started immediately, even before clinical signs appear. Monitor urine output closely; a decrease in urine output is an early sign of renal failure. Consider using SDMA as a more sensitive marker of renal function. Pitfalls: Do not induce emesis if the animal is already vomiting or showing signs of depression, as this may worsen aspiration. Avoid using corticosteroids concurrently with NSAIDs, as this increases the risk of gastrointestinal ulceration. Do not use H2 antagonists alone; they are less effective than proton pump inhibitors for preventing and treating ulcers. Do not delay fluid therapy while waiting for laboratory results. Do not use NSAIDs in animals with pre-existing renal or hepatic disease without careful consideration. Avoid using multiple NSAIDs simultaneously. Do not overlook the possibility of coagulopathy; check for bleeding tendencies. In chronic toxicity, do not discontinue treatment prematurely; monitor for weeks.

Based on Plumb's Veterinary Drug Handbook, the following protocols are recommended for NSAID toxicity: Decontamination: Apomorphine (dogs) 0.03 mg/kg IV or 0.04 mg/kg IM; if not effective, 0.25 mg/kg instilled in conjunctival sac. Activated charcoal 1-2 g/kg PO, with a cathartic such as sorbitol (70% solution at 3 ml/kg) or magnesium sulfate (250 mg/kg). Fluid therapy: Isotonic crystalloids (LRS or Normosol-R) at a rate of 60-90 ml/kg/day for maintenance, but for renal protection, administer at 2-3 times maintenance (e.g., 120-180 ml/kg/day) to promote diuresis. Monitor urine output; if oliguric, consider furosemide 1-2 mg/kg IV q8h, or mannitol 0.5-1 g/kg IV over 20 minutes, but only after adequate hydration. Gastroprotectants: Omeprazole 0.7-1 mg/kg PO q12h (dogs and cats); or pantoprazole 0.7-1 mg/kg IV q24h. Famotidine 0.5-1 mg/kg IV/PO q12h. Sucralfate 0.5-1 g PO q8h (dogs), 0.25-0.5 g PO q8h (cats). Misoprostol 2-5 mcg/kg PO q8h (dogs), but use with caution in cats. Anti-emetics: Maropitant 1 mg/kg SC q24h (dogs and cats); or ondansetron 0.1-0.2 mg/kg IV q8h. For hepatotoxicity: N-acetylcysteine 140 mg/kg IV loading dose, then 70 mg/kg IV q6h for 5-7 treatments. For seizures: Diazepam 0.5-1 mg/kg IV, or levetiracetam 20 mg/kg IV. For severe anemia: Packed red blood cells 10-20 ml/kg IV. For hyperkalemia: Regular insulin 0.1-0.2 U/kg IV with dextrose 2 g/U insulin, or calcium gluconate 0.5-1 ml/kg of 10% solution IV over 10-20 minutes. All dosages should be adjusted based on renal and hepatic function. Contraindications: Do not use corticosteroids, other NSAIDs, or anticoagulants concurrently. Use caution with aminoglycosides, which may worsen renal injury.

Several studies and consensus guidelines inform the management of NSAID toxicity. The ACVIM consensus statement on acute kidney injury (2016) emphasizes early fluid resuscitation and monitoring of urine output. A retrospective study by Khan et al. (2009) reported that dogs ingesting ibuprofen at doses >100 mg/kg developed renal failure, while doses >300 mg/kg were often fatal. Another study by Jones et al. (2012) found that carprofen overdose in dogs commonly caused gastrointestinal signs, but renal injury was less frequent. A study by Forrester et al. (2013) highlighted the increased susceptibility of cats to meloxicam toxicity, even at therapeutic doses, due to prolonged half-life. The use of misoprostol for NSAID-induced gastric ulcers was supported by a study by Wallace et al. (1994), which showed a reduction in ulcer formation. However, a more recent meta-analysis by Lanas et al. (2015) questioned the routine use of misoprostol due to side effects. The efficacy of proton pump inhibitors in preventing NSAID-induced ulcers was demonstrated in a study by Graham et al. (2002). For renal protection, a study by Cowgill et al. (2013) showed that aggressive fluid therapy and early intervention improved outcomes. The use of N-acetylcysteine for hepatotoxicity is supported by case reports and extrapolation from human studies. Overall, the evidence supports early decontamination, aggressive fluid therapy, and gastrointestinal protection as the mainstays of treatment.